BioCardia, Inc. Payments of Stock Issuance Costs
BioCardia, Inc. (BCDA) reported Payments of Stock Issuance Costs of $330.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-12
- BioCardia, Inc. payments of stock issuance costs for the quarter ending 2026-06-30 was $222.00K, a 1485.71% increase year-over-year.
- BioCardia, Inc. payments of stock issuance costs for the quarter ending 2026-03-31 was $108.00K, a 575.00% increase year-over-year.
- BioCardia, Inc. payments of stock issuance costs for the quarter ending 2025-12-31 was $96.00K, a 300.00% increase year-over-year.
- BioCardia, Inc. payments of stock issuance costs for the quarter ending 2025-09-30 was $804.00K, a 25.28% decline year-over-year.
- BioCardia, Inc. payments of stock issuance costs for fiscal 2025 was $930.00K, a 25.72% decline from fiscal 2024.
- BioCardia, Inc. payments of stock issuance costs for fiscal 2024 was $1.25M, a 89.12% increase from fiscal 2023.
- BioCardia, Inc. payments of stock issuance costs for fiscal 2023 was $662.00K, a 58.37% increase from fiscal 2022.
- BioCardia, Inc. payments of stock issuance costs for fiscal 2022 was $418.00K, a 608.47% increase from fiscal 2021.
| Period end | Payments of Stock Issuance Costs | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $222.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $330.00K 10-Q · filed 2026-08-12 | $426.00K derived: sum of 3 quarters · filed 2026-08-12 | $1.23M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | $108.00K 10-Q · filed 2026-05-15 | $204.00K derived: sum of 2 quarters · filed 2026-05-15 | $1.01M derived: sum of 3 quarters · filed 2026-05-15 | $1.02M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | $96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $900.00K derived: sum of 2 quarters · filed 2026-03-24 | $914.00K derived: sum of 3 quarters · filed 2026-08-12 | $930.00K 10-K · filed 2026-03-24 | |
| 2025-09-30 | $804.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $818.00K derived: sum of 2 quarters · filed 2026-08-12 | $834.00K 10-Q · filed 2025-11-12 | $858.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $30.00K 10-Q · filed 2026-08-12 | $54.00K derived: sum of 3 quarters · filed 2026-08-12 | $1.13M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | $16.00K 10-Q · filed 2026-05-15 | $40.00K derived: sum of 2 quarters · filed 2026-05-15 | $1.12M derived: sum of 3 quarters · filed 2026-05-15 | $1.18M derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $1.10M derived: sum of 2 quarters · filed 2026-03-24 | $1.16M derived: sum of 3 quarters · filed 2026-03-24 | $1.25M 10-K · filed 2026-03-24 | |
| 2024-09-30 | $1.08M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-11-12 | $1.14M derived: sum of 2 quarters · filed 2025-11-12 | $1.23M 10-Q · filed 2025-11-12 | $1.46M derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $62.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2025-10-29 | $152.00K 10-Q/A · filed 2025-10-29 | $379.00K derived: sum of 3 quarters · filed 2025-10-29 | $529.00K derived: sum of 4 quarters · filed 2025-10-29 | |
| 2024-03-31 | $90.00K 10-Q · filed 2025-05-14 | $317.00K derived: sum of 2 quarters · filed 2025-05-14 | $467.00K derived: sum of 3 quarters · filed 2025-05-14 | $572.00K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $227.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $377.00K derived: sum of 2 quarters · filed 2025-03-26 | $482.00K derived: sum of 3 quarters · filed 2025-03-26 | $662.00K 10-K · filed 2025-03-26 | |
| 2023-09-30 | $150.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $255.00K derived: sum of 2 quarters · filed 2024-11-13 | $435.00K 10-Q · filed 2024-11-13 | $622.00K derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-06-30 | $105.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $285.00K 10-Q · filed 2024-08-13 | $472.00K derived: sum of 3 quarters · filed 2024-08-13 | $538.00K derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $180.00K 10-Q · filed 2024-05-14 | $367.00K derived: sum of 2 quarters · filed 2024-05-14 | $433.00K derived: sum of 3 quarters · filed 2024-05-14 | $598.00K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $187.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $253.00K derived: sum of 2 quarters · filed 2024-03-27 | $418.00K derived: sum of 3 quarters · filed 2024-03-27 | $418.00K 10-K · filed 2024-03-27 | |
| 2022-09-30 | $66.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $231.00K derived: sum of 2 quarters · filed 2023-11-08 | $231.00K 10-Q · filed 2023-11-08 | $231.00K derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | $165.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $165.00K 10-Q · filed 2023-08-09 | $165.00K derived: sum of 3 quarters · filed 2023-08-09 | $157.00K derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-10 | $0.00 derived: sum of 2 quarters · filed 2023-05-10 | -$8.00K derived: sum of 3 quarters · filed 2023-05-10 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$8.00K derived: sum of 2 quarters · filed 2023-03-29 | $59.00K 10-K · filed 2023-03-29 | ||
| 2021-09-30 | -$8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $59.00K 10-Q · filed 2022-11-09 | |||
| 2021-06-30 | $67.00K 10-Q · filed 2022-08-10 | ||||
| 2020-12-31 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $1.48M derived: sum of 2 quarters · filed 2022-03-29 | $2.63M 10-K · filed 2022-03-29 | ||
| 2020-09-30 | $67.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.23M 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | $1.16M 10-Q · filed 2021-08-12 | ||||
| 2019-12-31 | $1.26M 10-K · filed 2020-04-09 | ||||
| 2018-12-31 | $200.00K 10-K · filed 2020-04-09 | ||||
| 2018-12-24 | $200.00K 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |